Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 1 1

Status

Completed 3Recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3Gynecologic 2Sarcoma 1Other solid neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 3

Interventions

Carboplatin 463Cisplatin 379Paclitaxel 313Pemetrexed 300Docetaxel 242Erlotinib Hydrochloride 240Gemcitabine 232pembrolizumab 173Radiotherapy 172Bevacizumab 169Nivolumab 130Etoposide 106Gefitinib 95Vinorelbine 84durvalumab 71atezolizumab 68Cetuximab 65Topotecan 61Drug Therapy 57Ipilimumab 55Irinotecan 54osimertinib 53Radiosurgery 52Afatinib 51Surveys and Questionnaires 38130-nm albumin-bound paclitaxel 38Albumin-Bound Paclitaxel 37Taxes 35Cyclophosphamide 35Surgical Procedures, Operative 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × chiauranib × Thoracic × Clear all
NCT04830813 2024-12-09

Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer

Chipscreen Biosciences, Ltd.

Phase 3 Completed
184 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT05371899 2024-07-15

Mass Balance Study of [14C]Chiauranib

Chipscreen Biosciences, Ltd.

Phase NA Completed
6 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT03216343 2023-08-30

Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer

Chipscreen Biosciences, Ltd.

Phase 1 Completed
48 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡